Loeb Katharine L, Bernstein Karen S, Dimitropoulos Gina
Chicago Center for Evidence Based Treatment, Chicago, Illinois, USA.
Department of Pediatrics, Division of Adolescent Medicine, University of Illinois, Chicago, Illinois, USA.
J Can Acad Child Adolesc Psychiatry. 2023 Aug;32(3):172-176. Epub 2023 Aug 1.
Atypical anorexia nervosa (AAN) has historically been underrecognized by clinicians due to traditional markers of low weight as indicative of malnutrition. Inadequate case identification can lead to treatment delays while placing children and adolescents with AAN at further risk of medical and psychiatric sequalae. The accompanying article in this journal issue examines the challenges of determining weight-based treatment goals for this population. In this commentary, we elaborate on this discussion and question the validity of weight stabilization as a treatment target in child and adolescent AAN. Furthermore, we address: (1) the role of weight and historical, variable, and stable growth curves in shaping treatment goals; (2) future growth targets, including numeric and remission targets; and; (3) the impact of weight stigma and implicit weight bias in clinical decision-making. We argue that target weights must take a secondary role in the treatment of AAN, shifting the focus to the mental, behavioural, and nutritional aspects of this disorder. In addition, we recommend that clinicians acknowledge and mitigate fears around weight gain and weight-based social rejection for young people and families in treatment.
非典型神经性厌食症(AAN)在历史上一直未得到临床医生的充分认识,因为传统上认为低体重是营养不良的标志。病例识别不足会导致治疗延误,同时使患有AAN的儿童和青少年面临更高的医学和精神后遗症风险。本期杂志的随附文章探讨了为这一人群确定基于体重的治疗目标所面临的挑战。在这篇评论中,我们详细阐述了这一讨论,并质疑体重稳定作为儿童和青少年AAN治疗目标的有效性。此外,我们还讨论了:(1)体重以及历史、可变和稳定生长曲线在制定治疗目标中的作用;(2)未来的生长目标,包括数值目标和缓解目标;以及(3)体重污名和隐性体重偏见在临床决策中的影响。我们认为,目标体重在AAN治疗中必须退居次要地位,将重点转向该疾病的心理、行为和营养方面。此外,我们建议临床医生认识并减轻治疗中的年轻人及其家庭对体重增加和基于体重的社会排斥的恐惧。